BOTOX® vs. XEOMIN® for Chronic Migraine

Abroad (travel likely)RecruitingPHASE3

Conditions

Chronic Migraine

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Naval Medical Center Camp Lejeune, Jacksonville, North Carolina, United States
Contact: Study coordinator (Keely Klaumann, BS) · keely.c.klaumann.ctr@health.mil · 910-226-2258

Study leads

Jacqueline S Buckley, PharmD
Principal Investigator
Naval Medical Center Camp Lejeune

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine

Chronic Migraine

Abroad (travel likely)RecruitingPHASE3

Chandler, United States · Phoenix, United States

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Chronic Migraine

Abroad (travel likely)RecruitingPHASE3

Huntsville, United States · Fayetteville, United States

A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine

Migraine

Abroad (travel likely)RecruitingPHASE3

Phoenix, United States · Long Beach, United States

The Nordic Chronic Migraine Trial of CGRP Monoclonal Antibody and Onabotulinumtoxin A Dual Therapy Compared to CGRP mAbs Monotherapy

Migraine · Chronic Migraine Headache

Abroad (travel likely)RecruitingPHASE3

Grålum, Norway · Kristiansand, Norway